ExeVir
ExeVir is a llama-derived antibodies founded in 2020.
B2X
Country
Email Address
info@exevir.com
Founded Date
2020
Headquarters
Investors
Latest Funding Round Date
May 24, 2021
Latest Funding Round Amount (USD)
27,000,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
50,000,000
Official Website
Find more companies like ExeVir
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.